CC-115 for Prostate Cancer - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adult patients with advanced prostate cancer that has spread beyond the prostate and has gotten worse after treatment with hormones (ADT).
What is Involved?
If you choose to join this study, you will:
- Have a screening period that includes a physical exam, collection of demographic data, imaging scans, a tumor biopsy and blood draws.
Once you have completed the screening period, you will:
- Take the study drug CC-115 with standard-of care-enzalutamide that will be taken by mouth at home
- Be asked to return to clinic weekly for the first 4 weeks, then every 8 weeks.
-- At these visits, you will get a medical exam, answer questions about any medications or adverse events, have routine blood tests
- Have imaging scans about every 2 months for the first 6 months and every 3 months after that.